Most recently, it has been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in identical locations as classical opioid receptors, it binds to the wide array of endogenous opioids. Not like most opioid receptors, this receptor functions like a scavenger https://robertd172mqp2.wikissl.com/user